Skip to content

A study comparing two surgical methods to improve nasal breathing in patients with nasal blockage

Surgical outcome of Microdebrider-Assisted Turbinoplasty Versus Submucosal Diathermy Turbinoplasty -A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102176
Enrollment
68
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J343- Hypertrophy of nasal turbinates

Interventions

Intervention1: Microdebrider assisted turbinoplasty: Microdebrider-assisted inferior turbinoplasty will be performed under local or general anesthesia. After nasal decongestion and submucosal infiltra

Sponsors

DR GUDURU LAKSHMI RAHUL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group between 18 to 60 years. 2. Both male and female patients. 3. Patients with isolated inferior turbinate hypertrophy. 4. Patients with nasal obstruction not responding to medical management.

Exclusion criteria

Exclusion criteria: 1. Patient refusal to participate in the study. 2. Presence of nasal polyposis. 3. Patients deemed unfit for surgery due to medical comorbidities. 4. Patients with previous history of inferior turbinoplasty or turbinate surgery.

Design outcomes

Primary

MeasureTime frame
To assess the effectiveness of Microdebrider-assisted Turbinoplasty versus Submucosal Diathermy Turbinoplasty in providing relief of nasal symptomsTimepoint: To follow up patients at 1week,1month and 3months

Secondary

MeasureTime frame
To compare the severity of postoperative complications between Microdebrider-assisted Turbinoplasty versus Submucosal Diathermy TurbinoplastyTimepoint: To follow up patients at 1week,1month and 3months

Countries

India

Contacts

Public ContactDR GUDURU LAKSHMI RAHUL

Aarupadai veedu Medical College

atulbage25@gmail.com9443292716

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026